TY - JOUR
T1 - Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the Literature
AU - Essa, Amr
AU - Macaraeg, Jeffrey
AU - Jagan, Nikhil
AU - Kwon, Daniel
AU - Randhawa, Saboor
AU - Kruse, Matthew
AU - Thomas, Stanley
AU - Velagapudi, Manasa
AU - Horne, John
AU - Narechania, Shraddha
AU - Kaster, Michael
AU - Valenta, Carrie
AU - Sahasranaman, Venketraman
AU - Moore, Douglas
N1 - Publisher Copyright:
© 2020 Amr Essa et al.
PY - 2020
Y1 - 2020
N2 - Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.
AB - Since the appearance of the E-Cigarette in the early 2000s, its industry, popularity, and prevalence have risen dramatically. In the past, E-Cigarette use with the vaping of nicotine or cannabis products had been associated with a few reported cases of lung injury. However, in 2019, thousands of cases of E-Cigarette or vaping product use-associated lung injury (EVALI) were reported in the United States. Evidence linked this outbreak with vaping of tetrahydrocannabinol (THC). We report two confirmed cases of EVALI and their associated clinical, radiologic, and pathologic features. This report supports the growing body of information regarding EVALI. It also discusses various substances, particularly vitamin E acetate, which has been suggested as a causative agent.
UR - http://www.scopus.com/inward/record.url?scp=85094570416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094570416&partnerID=8YFLogxK
U2 - 10.1155/2020/1090629
DO - 10.1155/2020/1090629
M3 - Review article
C2 - 32607271
AN - SCOPUS:85094570416
SN - 2090-6846
VL - 2020
JO - Case Reports in Pulmonology
JF - Case Reports in Pulmonology
M1 - 1090629
ER -